Skip to main content
Caplight Logo









Yellosis

Yellosis

Private
Gwacheon-siHealthcare & Life Scienceshttps://yellosis.com/

Last Round

Seed

Nov 1, 2020

Company Overview

Yellosis operates in Healthcare & Life Sciences and is based in Gwacheon-si. Its latest recorded funding round was a Seed round in November 2020.

Yellosis is a digital health company that provides AI-powered, urine-based diagnostic solutions for individuals and pets.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Subscription Commerce, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Yellosis Comparables

Compare Yellosis with similar companies based on industry and business-model similarity.

Yellosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanmu Biotechnology
81%
Yuurea Inc.
79%
Vivoo
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Yellosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Yukyung Tak

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Yellosis Investors

Notable investors and investment history

Yellosis investors
InvestorRounds
Samsung C-LabSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors grew 65% MoM, reaching 7K.

  • May 2, 2025

    Monthly visitors increased 164% MoM, reaching 2.9K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Yellosis Filings

Explore SEC and related filing metadata, where available.

Yellosis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Yellosis's valuation, stock price, and market status.

Is Yellosis a public or private company?

Yellosis is a private company.

What is the current stock price of Yellosis?

Yellosis is a private company, so its shares have no public market price. Caplight tracks Yellosis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Yellosis worth (valuation)?

Valuation information for Yellosis is not publicly available.

Can I buy Yellosis stock?

Yellosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Yellosis's last funding round?

Yellosis's most recent funding round was Seed on November 1, 2020.

Who are the main investors in Yellosis?

Key investors in Yellosis include Samsung C-Lab.

Will Yellosis IPO soon?

No public IPO plans have been announced for Yellosis.

How can I track Yellosis secondary market activity?

Caplight tracks bids, offers, and trades in Yellosis's shares on secondary markets.

Firmographic Details

HeadquartersGwacheon-si
Employee Range8
Year Founded2020
Last FundingNov 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?